SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic Evaluation of Pharmacogenomic-Guided Warfarin Treatment for Elderly Croatian Atrial Fibrillation Patients with Ischemic Stroke
5 references·0 citing·23 second hop
Economic Evaluation of Pharmacogenomic-Guided Warfarin Treatment for Elderly Croatian Atrial Fibrillation Patients with Ischemic Stroke (2015)Economic Evaluation of Pharmacogenomic-Gu…Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report (2009)Transferability of Economic E…Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI) (2008)Optimal Cost-Effectiveness De…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…The death of cost‐minimization analysis? (2001)The death of cost‐minimizatio…The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data (1998)The Use of the Bootstrap Stat…Cost-Effectiveness in Health and Medicine (1996)ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL (1996)Describing, explaining or predicting mental health care costs: a guide to regression models (2003)The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report (2009)Cost‐effectiveness of a collaborative dementia care management—Results of a cluster‐randomized controlled trial (2019)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Decision Modelling For Health Economic Evaluation (2006)Surrogates, meta‐analysis and cost‐effectiveness modelling: a combined analytic approach (2011)A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive–compulsive disorder in children/adolescents and adults (2016)Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models (2018)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Health Care Economic Analyses and Value-Based Medicine (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations (2021)The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective (2003)How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3) (2016)How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3) (2016)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 2009Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report535 cited
  • 2001The death of cost‐minimization analysis?437 cited
  • 2008Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI)290 cited
  • 1998The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data180 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work